WTF with ARX: Unlocking the power of regenerative healing

Stockhead’s Fraser Palamara is joined by ARX’s Dr Brian Ward to learn more about regenerative healing and what it offers.

What is regenerative healing? Why are such healing products used? And where does AROA sits in the greater regenerative healing market?

Aroa Biosurgery (ASX:ARX) founder and CEO Dr Brian Ward joins the Stockhead TV studio to investigate these questions and more.

ARX is a soft-tissue regeneration company committed to unlocking regenerative healing for everybody through its patented AROA ECM™ complex wound and tissue reconstruction products.

Stockhead’s Fraser Palamara is joined by ARX’s Dr Ward to learn more about regenerative healing and what it offers.

The interviews and discussions in this video are opinions only and not financial or investment advice.

Viewers should obtain independent advice based on their own circumstances before making any financial decisions.

Originally published as WTF with ARX: Unlocking the power of regenerative healing